News

CONRAD's Tenofovir Gel Scores Science Magazine's Breakthrough of the Year Top Ten List

Science Magazine, December 16, 2010
December 20, 2010

Congratulations to all involved in the CAPRISA 004 and iPrEx trials - tenofovir gel and iPrEx's study of Truvada received high honors from Science Magazine, both listed as runners up for Breakthrough of the Year.  According to Science:  "Neither approach is a magic bullet, AIDS researchers say. But in combination with other measures, they could usher in a new era of HIV prevention."  Go to page three of the attached pdf for more information. 

Additional Documents

1911 North Fort Myer Drive, Suite 900, Arlington, Virginia 22209   T: (703) 524-4744 | info@conrad.org